AUSTIN RUSHER: Open Payments
NPI 1578165445 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 7 payments from 7 companies in 2025. Trend: 2023 $117 · 2024 $135 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $22 |
| CooperSurgical, Inc. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: Veozah, APTIMA, Paragard T 380A, SLYND, MYFEMBREE, INJECTAFER, MOUNJARO.
Industry payments across MT — which companies pay providers there.
